Durham, NC
Other
Updated 1 year ago

Darolutamide Demonstrates Favorable Tolerability, Decreased Metastatic Progression in nmCRPC

Reporter: Onclive

 Darolutamide Demonstrates Favorable Tolerability, Decreased Metastatic Progression in nmCRPC

Share your feelings about this article

Marvellous Icon Interaction animation marvellous Image

Marvellous00

Article Interaction Bullseye Image Interaction Animation Bullseye Image

Right on00

Article Interaction Good Image interaction animation good

Good00


A A+ A++ A+++
Daniel J. George, MD Treatment with darolutamide (Nubeqa) decreased the likelihood of developing metastatic disease or discontinuing treatment because of ad...

Go to original article source

Related : Kids need to go back to school

Reporter

Phoenix, AZ

26

Articles

0

Followers

106

Views

Overall Article Rating:
0.0
View Article Ratings
Contributions (0)
Add Contribution+2 pts.

A contribution is an additional perspective to the primary article. You may add your contribution to the article and it will be featured below the primary article. Each contribution will follow the article in order of date added.

Comment (0) Details Min. 25 characters required | (500 characters limit) This is the exciting part of article , add your valuable comment.
Add Comment+1 pt.
Durham, NC